Lung concentrations of telithromycin after oral dosing

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 6, 2001, Pages 837-840

  Khair, O A ^a   Andrews, J M ^a   Honeybourne, D ^b   Jevons, G ^a   Vacheron, F ^c   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; TELITHROMYCIN; THEOPHYLLINE;

ADULT; ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; EPITHELIUM; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; MALE; MEASUREMENT; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TIME; TISSUE WATER; VOMITING;

EID: 0034986363     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.6.837     Document Type: Article

References (5)

1. Ketolides: Semisynthetic 14-membered-ring macrolides
2. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy
3. Simplified, accurate method for antibiotic assay of clinical specimens
4. The levels of clarithromycin and its 14-hydroxy metabolite in the lung
5. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease